BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11566906)

  • 21. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
    Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
    Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Eguchi S; Numaguchi K; Iwasaki H; Matsumoto T; Yamakawa T; Utsunomiya H; Motley ED; Kawakatsu H; Owada KM; Hirata Y; Marumo F; Inagami T
    J Biol Chem; 1998 Apr; 273(15):8890-6. PubMed ID: 9535870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation.
    Deb TB; Wong L; Salomon DS; Zhou G; Dixon JE; Gutkind JS; Thompson SA; Johnson GR
    J Biol Chem; 1998 Jul; 273(27):16643-6. PubMed ID: 9642214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells.
    Xi XP; Graf K; Goetze S; Fleck E; Hsueh WA; Law RE
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):73-82. PubMed ID: 9888869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling.
    Keilhack H; Tenev T; Nyakatura E; Godovac-Zimmermann J; Nielsen L; Seedorf K; Böhmer FD
    J Biol Chem; 1998 Sep; 273(38):24839-46. PubMed ID: 9733788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
    Watts SW; Florian JA; Monroe KM
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
    Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL
    Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1.
    Feng YH; Sun Y; Douglas JG
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12049-54. PubMed ID: 12221292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.
    Kapoor GS; Zhan Y; Johnson GR; O'Rourke DM
    Mol Cell Biol; 2004 Jan; 24(2):823-36. PubMed ID: 14701753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases.
    Shi ZQ; Lu W; Feng GS
    J Biol Chem; 1998 Feb; 273(9):4904-8. PubMed ID: 9478933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
    Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM
    Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells.
    Eguchi S; Iwasaki H; Inagami T; Numaguchi K; Yamakawa T; Motley ED; Owada KM; Marumo F; Hirata Y
    Hypertension; 1999 Jan; 33(1 Pt 2):201-6. PubMed ID: 9931105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-beta gene expression via transcriptional and post-transcriptional mechanisms.
    Matsubara H; Moriguchi Y; Mori Y; Masaki H; Tsutsumi Y; Shibasaki Y; Uchiyama-Tanaka Y; Fujiyama S; Koyama Y; Nose-Fujiyama A; Iba S; Tateishi E; Iwasaka T
    Mol Cell Biochem; 2000 Sep; 212(1-2):187-201. PubMed ID: 11108151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells.
    Giasson E; Servant MJ; Meloche S
    J Biol Chem; 1997 Oct; 272(43):26879-86. PubMed ID: 9341120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
    Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
    Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts.
    Tao X; Fan J; Kao G; Zhang X; Su L; Yin Y; Zrenner B
    Biol Cell; 2014 Jun; 106(6):182-92. PubMed ID: 24641355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms.
    Deguchi J; Makuuchi M; Nakaoka T; Collins T; Takuwa Y
    Circ Res; 1999 Oct; 85(7):565-74. PubMed ID: 10506481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent roles of SHP-2 in ERK activation by leptin receptors.
    Bjørbaek C; Buchholz RM; Davis SM; Bates SH; Pierroz DD; Gu H; Neel BG; Myers MG; Flier JS
    J Biol Chem; 2001 Feb; 276(7):4747-55. PubMed ID: 11085989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis.
    Lehtonen JY; Daviet L; Nahmias C; Horiuchi M; Dzau VJ
    Mol Endocrinol; 1999 Jul; 13(7):1051-60. PubMed ID: 10406457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts.
    Ruiz-Ortega M; Egido J
    Kidney Int; 1997 Dec; 52(6):1497-510. PubMed ID: 9407495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.